Focus Partners Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218M Buy
237,125
+14,883
+7% +$15.1M 0.24% 91
2025
Q4
$237M Buy
222,242
+58,320
+36% +$55.8M 0.27% 77
2025
Q3
$124M Buy
163,922
+12,694
+8% +$9.45M 0.2% 93
2025
Q2
$118M Buy
151,228
+27,593
+22% +$21.4M 0.26% 77
2025
Q1
$102M Buy
123,635
+4,738
+4% +$3.94M 0.26% 84
2024
Q4
$91.8M Buy
118,897
+46,932
+65% +$38.9M 0.24% 91
2024
Q3
$63.8M Sell
71,965
-54,447
-43% -$49M 0.2% 108
2024
Q2
$114M Buy
126,412
+79,621
+170% +$63.7M 0.39% 63
2024
Q1
$36.4M Buy
46,791
+15,224
+48% +$10.8M 0.3% 86
2023
Q4
$18.4M Buy
+31,567
New +$18.4M 0.24% 113

Other funds holding LLY

Focus Partners Wealth's LLY Position: Q1 2026 in Review

Focus Partners Wealth increased its Eli Lilly (LLY) stake by 6.7% in Q1 2026, buying an estimated $15.1M and bringing the position to 237,125 shares worth $218M. The position accounts for 0.24% of the portfolio, ranked #91.

Focus Partners Wealth first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $237M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Focus Partners Wealth held 237,125 shares of Eli Lilly worth $218M as of Q1 2026.
  • Focus Partners Wealth bought 14,883 Eli Lilly shares in Q1 2026, an estimated $15.1M.
  • Eli Lilly made up 0.24% of Focus Partners Wealth's portfolio in Q1 2026, its #91 holding.
  • Focus Partners Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Focus Partners Wealth's Eli Lilly position peaked at $237M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.